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SUMAIARY
In a recent survey of trimethoprim resistance, 357 Gram-negative aerobic
organisms were isolated from healthy volunteers from rural and urban populations
in South Africa. Trimethoprim resistance did not transfer to an Escherichia coli
J62-2 recipient strain by conjugation in a liquid mating in 161 (45 1 %) of the
isolates. These isolates which did not transfer their resistance were probed with
intragenic oligonucleotide probes for the types Ia, Ib, Illa, V, VI, VII, VIII, IX,
X and XII dihydrofolate reductase genes. Contrary to all previous data, the most
prevalent dihydrofolate reductase gene in this group of non-transferable isolates
which hybridized, was the type VII (38%) followed by the type Ia (25%), lb
(12%), V (1-7%) and VIII (1-2%). None of the strains hybridized to the types
Illa, VI, XI, X and the XII dihydrofolate reductase probes. Southern blots of
plasmid and chromosomal DNA from selective isolates revealed that the type VII
dihydrofolate reductase genes were located on the chromosome and were
associated with the integrase gene of Tn2l. However, the type lb and Vr
dihydrofolate reductase genes were all found on plasmids which could not be
mobilized. The type Ia dihydrofolate reductase genes were found on both non-
transferable plasmids and on the chromosome. The nature of the genetic
structures associated with a dihydrofolate reductase gene strongly affects the
means of spread of the gene in a population.
INTRODUCTION
Trimethoprim is a broad-spectrum antimicrobial agent used on its own or in
combination with sulphamethoxazole in the treatment of Gram-negative
infections. Trimethoprim selectively inhibits the bacterial dihydrofolate reductase
(DHFR) thus preventing reduction of dihydrofolate to tetrahydrofolate [1]. The
most common mechanism of resistance to trimethoprim in Enterobacteria is the
production of an additional plasmid mediated DHFR which unlike the
chromosomal enzyme, is less sensitive to inhibition by trimethoprim [2]. Fifteen
of these trimethoprim resistant enzymes have been identified in Enterobacteria
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and have been characterized according to their biochemistry and DNA sequence.
They are the Ia [3], lb [4], Ila [5], Ilb [6], Ile [7], Illa [8], IIIb [9], IIIc [10]
renamed the type VIII [11], IV [12], V [13], VI [14], VII [15], IX [16], X [17] and
XII [18].
Since the introduction of trimethoprim to South Africa, high levels of resistance
(48-5 %) have been recorded among hospital isolates of Gram-negative aerobic
bacteria [19]. The high incidence of trimethoprim resistance is cause for concern
as it increases the number of treatment failures and limits the available choice of
antibiotics for therapy. The problem of antimicrobial resistance is further
complicated by the presence of plasmids bearing resistance factors to more than
one therapeutic agent.
It has been suggested that the faecal flora may act as a reservoir for antibiotic
resistance genes with the potential for transfer to human pathogens [20]. Levy and
colleagues [21] suggested that resistance genes may possibly be transferred to
pathogens via bacteriophage or transposable elements. Trimethoprim resistant
DHFR genes have also been found as cassettes capable of site-specific insertion
into integrons [22]. This mechanism has the potential for the development of
multiple resistance on a single mobile genetic element. In some individuals
resistant organisms constitute a major fraction of the gut flora [23]. Resistance in
faecal flora is important since these organisms are thought to be implicated in
infection of the urinary tract [24].
Trimethoprim resistance at first world centres has been dominated by the Tn7
mediated type Ia DHFR [16, 25-27]. Much of the success of the type la DHFR
is based on its ability to integrate as part of Tn7 into the attTn7 site on the
chromosome of E. coli and other bacteria [28]. This promiscuous transposon has
also been found integrated into random sites on the chromosome and on plasmids
albeit at a lower frequency [29]. The type Ia DHFR is found as part of a cassette
like structure thus giving it the potential to be inserted by integrase activity into
integron like structures of different genetic elements. The type Ia DHFR has been
found within integron structures of Tn7 and the antimicrobial resistance integron
of the predominantly plasmid located transposon Tn21 [30].
A study by Heikkila and colleagues [26] found the type Ia DHFR on the
chromosome in 75 out of 76 isolates. Nine of these isolates carried the type Ia
DHFR on both the plasmid and chromosome and only one isolate carried the gene
on a plasmid only. Of these isolates, 61 (80%) probed positive for the tnsC gene
suggesting an active Tn7. Fifty of these isolates (82%) had Tn7 located in the
attTn7 site. The type II, V, VII and XII DHFRs have all been found as cassette
structures on self transmissible plasmids in the integron of Tn2l like elements
[13, 31]. The following other DHFRs have been observed to contain the
characteristic repeats that suggest that the gene forms part of a cassette: VI [15]
and the type lb of Tn 4132 [32].
Little is known about the epidemiology or genetic location of trimethoprim
resistance determinants in third world countries. Surveys from Sri Lanka [33] and
South Africa [19] showed there to be a low prevalence of the type Ia DHFR. A
study of commensal flora from South India showed that the most prevalent
DHFR was the type V [34]. In Taiwan the frequency of the type Ia and type V
DHFRs in urine isolates was 45-4 % and 10o4% respectively [35].
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A recent study of antimicrobial resistance showed that the occurrence of
trimethoprim resistance in Gram-negative aerobic faecal flora isolated from rural
and urban black populations in South Africa was 74-2% [36]. The trimethoprim-
resistant isolates from this survey were further studied [37] and in these isolates,
the prevalence of transferable plasmid mediated DHFRs detected with oligo-
nucleotide probes was as follows: type lb (30%), VIII (23%), V (13%), Ia (6%),
VII (3%) and XII (0-5%) [38]. This paper reports the non-transferable DHFRs
that were identified with oligonucleotide probes and investigates the genetic
location of some of these genes.
METHODS
Conjugation
Conjugation experiments were performed in liquid media by the method of
Amyes and Gould [39]. Escherichia coli K- 12 strain J62-2 (his trp pro rifr) was used
as the recipient. Isolates resistant to rifampicin were mated with E. coli K-12
strain J62-2 (his trp pro nalr). The selective medium used was Davis Mingioli
minimal medium [40] with 2 8 g/l glucose, 10 mg/l trimethoprim (Wellcome
Medical Division, Crewe, UK), 25 mg/l rifampicin (Gruppo Lepetit, Milan, Italy)
or 20 mg/l nalidixic acid (Sanofi Winthrop, Gilford, UK). supplemented with
50 mg/l histidine, 50 mg/l proline and 50 mg/l tryptophan. Colonies were purified
on selective medium and their auxotrophic requirements checked on Davis
Mingioli minimal agar supplemented with 2-8 g/l glucose. With those strains that
did not transfer their trimethoprim resistance, a triple mating was set up with an
X+ factor as the mobilizing plasmid [41].
Filter matings were performed with a rifampicin resistant mutant of E. coli
K802 (hsdR, metB) [42]. Matings were prepared by passing 1 ml of 1:10 mixture
of an overnight culture of donor and recipient strain respectivelY through sterile
13 mm cellulose nitrate filters (pore size 0 45 ,um). The filters were placed onto the
surface of isosensitest agar and incubated overnight at 22 °C or 37 'C. The filters
were placed in 10 ml of Davis Mingioli minimal medium and shaken vigorously. A
100 1a1 of this mixture was plated out onto isosensitest agar with 10 mg/l of
trimethoprim and 25 mg/l of rifampicin. The auxotrophic requirements of the
transconjugants were confirmed on Davis Mingioli minimal agar supplemented
with 2-8 g/l glucose.
DNA isolation
Plasmid DNA was isolated as described previously [37]. Total DNA was isolated
by the following method. All manipulations were carried out at room temperature
in 1-5 ml micro centrifuge tubes unless otherwise stated. Cells were harvested from
0 5 ml of overnight Luria broth culture and resuspended in 350 ,ul of HTE buffer
(50 mM-Tris-Cl, pH 8-0, 20 mM-EDTA). An equal volume of 2% N-lauroyl-
sarcosine in HTE buffer was added and incubated at 55 'C for 30 min to lyse the
cells. The lysate was cooled then extracted with one volume of phenol: chloroform
(1:1, equilibrated with 05 M-Tris-Cl, pH 80). One volume of isopropanol was
added to the supernataht and the DNA was precipitated for 10 min prior to
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Table 1. Oligonucleotides for DHFR gene probes
DHFR Oligonucleotide sequence
Type Ia 5'-CAAGTTTTACATCTGAC(AAT-GAGAACGTAT-3'
Type lb 5'-(TTGGACATCAAATGATGACAATGTAGTTG-3'
Type Illa 5'-ATCCCCAATGGCCAGGCCGAAGGGGTGGAGG- 3'
Type VIII 5'-AAGCGCTGGAGCTTCCoXGGTGTTCGTGACG- 3'
Type V 5'-CCTGGAC(4GCCG(ATAATGACAACGTAATA(G-3'
Type VI 5'-(TAAAATTATCTCGAATGACCCTGATGTTG-3'
Tvpe VII 5'-GAATTTCAAGCTCAAATGAAAATGTATTAG-3'
Type IX 5'-CAGTACCACCCACCCAGAACACTGATCAAG-3'
Type X 5'-CAACTATCACAGAGCACGAAGTGCTCAACA-3'
Type XII 5'-AAGCTAACTACCGCGCCACTGGCTGCGTAG-3'
Origin/Reference
DNA sequence:
429-459 bp [3]
DNA sequence:
430-460 bp [32]
DNA sequence:
298-328 bp [8]
DNA sequence:
779-809 bp [11]
DNA sequence:
1501-1531 bp [13]
DNA sequence:
528-558 bp [14]
DNA sequence:
789-819 bp [15]
DNA sequence:
924-954 bp [16]
DNA sequence:
848-878 bp [17]
DNA sequence:
414-444 bp [18]
centrifugation. The pellet was resuspended in 50,u of H20 with 20,ug/ml of
RNase.
Probe construction
Probes to distinguish between the type lb and V DHFRs were used as described
by Young and colleagues [32]. The region used is very heterogeneous between
these two genes. Considerable heterogeneity occurs in the same region throughout
all resistant DHFRs and this region was selected for the construction of 30 bp
oligonucleotide probes for the type Ia, Ib, Illa, VIII, V, VI, IX, X, and XII
DHFR genes. The nucleotide sequence of the 30mer oligonucleotide probes for the
DHFRs appear in Table 1. All of the oligonucleotide probes were tested for
homology with other DNA sequences on the GenBank database. The probe for the
integrase gene of Tn7 was previously described [26]. The probe for the integrase
gene of Tn2l was a 22mer oligonucleotide probe 5'-GTCAAGGTTCTGGACCA-
GTTGC-3' from the integrase gene of Tn2l [it]. The oligonucleotide probes were
labelled using the ECL Oligo labelling and detection kit (Amersham, UK). The
type II gene probe consisted of a 280 bp EcoR I, Sau3A I intragenic fragment of
pWZ820 [43] and was labelled using the ECL Randomprime labelling and
detection kit (Amersham, UK). Table 2 shows the control strains that were used
with the probes.
Preparation of Dot Blots
Total DNA isolated from the transconjugants was denatured by the addition of
one volume of 1 M-NaOH followed by a 10 min incubation at 37 'C. DNA
concentrations were determined by agarose gel electrophoresis and 500 ng of DNA
was spotted onto nitro-cellulose membranes (DuPont Genescreen, Germany). The
membranes were dried then baked at 80 'C for 2 h.
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Table 2. Control plasmids used in hybridization protocols
DHFR Plasmid Reference or origin
Type Ia pFE506 [3]
Type lb pUK163 [32]
Type Ila R67 [44]
Type IIb R388 [6]
Type Ile R751 [7]
Type Illa pAZI [8]
Type Illb pBH600 [10]
Type VIII pBH700 [10]
Type IV pKlK1123 [45]
Type V pLMO20 [33]
Type VI pUK672 [46]
Type VII pLMO226 [33]
Type IX pCJOO1 [16]
Type X pMAQ41 [17]
Type XII pBEM155 [18]
Southern hybridization
Plasmids were isolated as described previously [37]. Plasmid and total DNA was
run on 08% agarose gels and Southern blotted onto nitrocellulose membranes
(Amersham, Hybond C-Extra). Total DNA that was restricted with EcoR I or
BamH I was run on 1% agarose gels before Southern blotting.
Hybridization with oligonucleotide probes
Hybridization was carried out with the ECL Oligo labelling and detection kit
(Amersham, UK). The hybridization was performed for 2 h at 53 °C according to
the manufacturer's recommendations. Stringency washes were performed as
described previously [26].
Hybridization with gene probes
Hybridization was carried out with the ECL Randomprime labelling and
detection kit (Amersham, UK). The blots were hybridized overnight at 62 °C
according to the manufacturer's recommendations with the following stringency
washes: two 15 min washes with 1 x SSC and 0-1 % SDS followed by two 15 min
washes with 0-05 x SSC and 0 1 % SDS at 62 'C. The type Ilb and IIc were used
as positive controls.
RESULTS
The oligonucleotide probes discriminated well between the DHFRs and no cross
hybridization was observed with any of the negative controls. Out of 357 isolates
of trimethoprim resistant Gram-negative commensal faecal flora isolated from
healthy volunteers from rural and urban populations, resistance was transferable
to a recipient strain (E. coli J62-2) in a liquid mating in 184 (51-5%) of the isolates.
A further 12 (34%) plasmids could be mobilized into E. coli J62-2 in a triple
mating with an X+ factor. Total DNA from the 161 (45-1 %) of the isolates which
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Table 3. Frequency of resistant DHFRs in South African commensal faecal flora
DHFR Transferred by conjugation (0) Non-transferable (0) Total (%)
Ty-Pe la 11 (3 1) 41 (11 5) 52 (14 6)
Type lb 58 (16 2) 20 (5 6) 78 (21 8)
Tvpe VIII 45 (126) 1 (03) 46 (129)
Type VT 25 (70) 3 (08) 28 (78)
Type VII 5 (1.4) 62 (17 4) 67 (18 8)
Type XII 1 (03) 0 1 (03)
Utnknown 52 (14 6) 38 (10 6) 90 (25 2)
Table 4. Frequency of non-transferable DHFRs and the organism of origin
DHER Hybridization (0) Species
Type la 41* (11 5) E. coli (32)
Klebsiella spp. (3)
Enterobacter spp. (4)
Citrobacter spp. (1)
Proteus vldgaris (1)
Type lb 20 (56) E. coli (14)
Klebsiella spp. (6)
Type V'III 1 (0 3) Citrobacter sp. (1)
Type V 3 (0 8) E. coli (1)
Klebsiella spp. (2)
Type VII 62 (17-4) E. coli (57)
Klebsiella spp. (3)
Enterobacter spp. (2)
* Of the isolates which hybridized to the type Ia probe, four also hybridized with the type
VII probe and one h bridized with the type V'III probe.
did not transfer their resistance to a recipient strain, was probed for the presence
of the types Ia, Ib, Ilb, Ile, Illa, VIII, V, VI, VII, IX, X and XII DHFR genes.
A comparison of the hybridization frequencies of the DHFR genes, which were
transferable by conjugation and those which did not transfer to E. coli J62-2, is
shown in Table 3.
Of the isolates which did not transfer their resistance, the most prevalent
DHFR type was the type VII which occurred in 62 (174%) of the isolates. The
second most prevalent DHFR was the type Ia 41 (11-5%), followed by the type
lb 20 (5-6%), the type V, three isolates and the VIII two isolates. The species
distribution of the isolates, which hybridized to each probe is shown in Table 4.
Five isolates hybridized to more than one DHFR probe, four of which hybridized
to both to the type Ia and VII DHFR probes and one isolate to the types Ia and
VIII DHFR probes. Since there was no cross hybridization with the control
strains, it appears that two resistant DHFR genes are present in these isolates.
None of the isolates hybridized to the probes for the types Ilb, Ilc, Illa, VI, IX
and XII DHFR genes. Thirty-eight isolates did not hybridize to any of the DHFR
probes.
Representative isolates carrying each DHFR type were randomly selected.
Plasmid and total DNA from each isolate was separated on a 0-8 % agarose gel,
Southern blotted then probed to determine the genetic location of the DHFR
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Fig. 1. (a) 0-8% Agarose gel of plasmid and total DNA preparations from seven isolates
which hybridized to the probe for the type VII DHFR. (b) Southern blot showing the
chromosomal location of the type VII DHFR gene. VII, Plasmid pLMO226 control;
P, Plasmid DNA; T. Total DNA.
gene. The type VII DHFR gene was found located on the chromosome in all the
isolates tested (n = 9). Figure 1 shows the agarose gel and the Southern blot of
seven of these isolates. Sixteen isolates harbouring a non-transferable type VII
D)HFR gene including these nine isolates were further analysed by Southern
blotting a BamH I restriction of the chromosomal DNA and probing it with
oligonucleotide probes for the type VII DHFR and the integrase gene of Tn2l
(Fig. 2). For each isolate both probes hybridized positively to fragments of the
same size.
The chromosomal DNA probed positive in 8 out of 9 isolates which hybridized
to the type Ia DHFR probe. In the remaining isolate the type Ia DHFR was
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Fig. 2. (a) 1% Agarose gel of restricted total DNA preparations from isolates which
hybridized to the probe for the type VII DHFR. (b) Southern blot showing the
fragment sizes whiceh hybridized to the type VII DHFR probe. Lanes 1, Hind III
restricted A DNA; 2, BaniH I restricted pLMO226 control DNA; 3-18, BamnH I
restricted total DNA from isolates which hybridized to the type VII DHFR probe; 19,
EcoR I restricted pLMO226 control DNA.
Table 5. Genetic location of DHFR genes and associated integrase genes
DHFR
Type la
Type lb
Type
Type VII
(n) Location of DHFR Associated transposon
9 Chromosome (8) Tn7 (7)
Plasmid (1) Tn2l (1)
7 Plasmid (7) Tn2J (2)
3 Plasmid (3) Tn2J (3)
9 (hromosome (9) Tn2J (9)
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Fig. 3. (a) 0-8 0 Agarose gel of plasmid and total DNA preparations from seven isolates
which hybridized to the probe for the type lb DHFR. (b) Southern blot showing the
plasmid location of the type lb DHFR gene. Ib, Plasmid pUK163 control; P, Plasmid
DNA; T. Total DNA.
located on a plasmid. A southern blot of EcoR I restricted chromosomal DNA
from these isolates revealed a number of fragments of variable size which
hybridized to the type Ia DHFR probe. The probe for the integrase gene of Tn7
hybridized to fragments of the same size in 7 out of 8 chromosomal mediated
dhfrla bearing isolates. The plasmid carrying the type Ia DHFR gene probed
positive for the integrase gene of Tn2l (Table 5). Attempts to mobilize this
plasmid into a restriction endonuclease deficient recipient (E. coli K802) in a filter
mating at 22 °C and 37 °C were not successful.
Southern hybridizations of plasmid and total DNA from seven isolates that
probed positive for the type lb DHFR gene revealed that the type lb DHFR gene
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in these isolates was plasmid mediated (Fig. 3). A small 9 kb plasmid was present
in 5 out of 7 of these isolates. The two larger plasmids hybridized positively to the
integrase gene of Tn2l. All three isolates which hybridized to the type V DHFR
probe were found to be plasmid mediated and associated with the integrase gene
of Tn2l. None of these plasmids bearing the type of lb and V DHFR genes could
be mobilized into E. coli K802 in a filter mating at 22 °C and 37 °C.
DISCUSSION
The distribution of the DHFR genes which could not transfer their resistance
by conjugation is completely different from the distribution of these genes located
on transferable plasmids. This suggests that the genetic structures associated with
these genes play an important role in the dissemination and spread of these genes.
The type VII DHFR gene has been reported to be geographically widespread
[15]. The incidence of the type VII DHFR that was recorded in this study is
considerably higher than that found in any previously studied population. What
is of considerable interest is the contrast between the small number out of the total
sample of 357 isolates bearing this gene on self transmissible plasmids in
comparison to the large number of isolates that harbour this gene on the
chromosome. The number of different species carrying the type VII DHFR gene
(Table 4), the number of different plasmid profiles represented by the isolates (Fig.
1 a), and the different fragment sizes which hybridized to the type VII DHFR and
Tn2l integrase genes, suggest the widespread dissemination of this DHFR gene is
not the result of the spread of a single clone.
The type VII DHFR has in previous studies been located within a Tn2l like
element on transferable plasmids [15] although no other locations for the type VII
gene have been documented in the literature. The close association of the type VII
DHFR gene with the integrase gene of Tn21 in the South African population
suggests that the type VII DHFR gene is integrated into an integron-like
structure. The number of different sized restriction fragments that showed this
combination of these two genes suggest that the integrase may be incorporated
into a number of different Tn21 like elements such as Tn8O56 [15] which may
insert at random sites into the chromosome. It is unclear why the integrase gene
of Tn2l which is normally associated with DHFR genes on plasmids
[13, 15, 26, 31] should show a preference for integration into the chromosome.
Although the genetic structures associated with the spread of the type Ia
DHFR appear to be similar to those reported by Heikillia and colleagues [26], the
frequency of the type Ia DHFR in South African populations is considerably
lower thaii that reported in other populations.
In contrast to the type Ia and VII DHFRs, the DHFR genes which probed
positive for the type lb and V DHFRs were located on plasmids in the isolates
that were tested. These plasmids appear to be stable and could not transfer their
resistance by conjugation under a variety of conditions. The origins and
mechanisms of dispersal of these plasmids is difficult to determine. However it
appears that these phenomena may account for a larger proportion of non-
transferable resistance factors than previously expected.
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